Kentaro Suzuki - Sep 16, 2024 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role: Chief Marketing Officer
Signature: /s/ Matthew Murphy, as Attorney-in-Fact
Stock symbol: NAUT
Transactions as of: Sep 16, 2024
Transactions value $: $0
Form type: 4
Date filed: 9/17/2024, 04:47 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NAUT	Stock Option (Right to Buy)	Award	$0	+375K		$0.00	375K	Sep 16, 2024	Common Stock	375K	$2.96	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the reporting person remains a Service Provider as provided in the Company's 2021 Equity Incentive Plan through each such vesting date. The Vesting Commencement Date is September 16, 2024.

Content

25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the reporting person remains a Service Provider as provided in the Company's 2021 Equity Incentive Plan through each such vesting date. The Vesting Commencement Date is September 16, 2024.